PUBLISHER: DelveInsight | PRODUCT CODE: 1439246
PUBLISHER: DelveInsight | PRODUCT CODE: 1439246
Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030
The global coronary stents market was valued at USD 9.27 billion in 2023, growing at a CAGR of 7.51% during the forecast period from 2024 to 2030, to reach USD 14.28 billion by 2030. The rise in demand for coronary stents is primarily attributed to the rising prevalence of cardiovascular disorders such as stroke, atherosclerosis, and heart attack due to the increasing geriatric population; a growing number of PCI (Percutaneous Coronary Intervention) procedures; increase in demand for minimally invasive surgeries, and technological advancement in the product line, among others.
Coronary Stents Market Dynamics:
One of the key factors influencing the growth of the coronary stents market is the increasing prevalence of various cardiovascular diseases across the globe. For instance, according to the American Heart Association 2022, globally, about 244.1 million people were living with coronary (ischemic) heart disease in 2020.
As per the data provided by British Heart Foundation 2022, in 2019 coronary heart disease remained one of the most prevalent cardiovascular conditions worldwide accounting for about 200 million cases globally.
The increasing number of risk factors such as old age, obesity, smoking, and others causing the development of cardiovascular diseases in one or another way are further driving the market growth for coronary stents. For instance, according to the data provided by the WHO (2023), in 2020, about one billion people across the world were over the age of 60. The elderly population aged 60 and above is expected to double in number representing about 2.1 billion people by 2050.
Thus, the increasing prevalence and mortality rate from the above-mentioned disorders can be either managed or reduced by providing proper treatment using coronary stents, thereby leading to an increased demand for the device. Therefore, the afore-said factor will propel the overall market of coronary stents in the upcoming years.
Certain factors such as increasing product recalls, and stringent regulatory approval processes may pose a minor hurdle to the growth of the coronary stents market.
Coronary Stents Market Segment Analysis:
Coronary Stents By Product Type (Bare Metal Stents, Drug Eluting Stents, and Drug-Coated Stents), Material (Metals [Stainless Steel, Cobalt-Chromium (CoCr), Platinum-Chromium (PtCr), and Nitinol] and Polymers), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Coronary Stents product segment, the drug-eluting stent is expected to hold the largest market share during the forecast period. This is due to the various advantages of drug-eluting stents over bare metal stents and others.
Drug-eluting stents are more effective in the prevention of restenosis than the use of bare-metal stents, the use of newer-generation drug-eluting stents also reduces the rate of stent thrombosis and myocardial infarction. For instance, as per research studies, there was a 0.5% rate of stent thrombosis at 5 years among a relatively low-risk population of patients.
Moreover, recent product approval is also anticipated to further boost the market the drug-eluting coronary stent market. For instance, in 2020, SCITECH Medical received CE Mark approval for its third-generation drug-eluting stent, INSPIRON Coronary Sirolimus Eluting Stent.
Therefore, the aforementioned factors are likely to propel the segmental growth of the coronary stents market.
North America is expected to dominate the overall Coronary Stents Market:
Among all the countries, North America is expected to dominate the overall coronary stents market during the forecast period. This domination is due to the rising prevalence of coronary heart diseases and other CVDs, improved healthcare infrastructure, and favorable reimbursement scenarios in the region among others.
The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020. Also, the same source stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent-the damage is done, but the person is not aware of it.
In addition, the presence of key manufacturers such as Medtronic, and Boston Scientific Corporation, among others is also likely to boost the coronary stents market. Furthermore, recent product approval in the region will also contribute to the market growth. For instance, in 2019, German medical device company Biotronik received US Food and Drug Administration (FDA) approval for Orsiro drug-eluting coronary stent (DES) system.
Hence, the above-mentioned factors are contributing in regional market growth during the forecast period.
Coronary Stents Market Key Players:
Some of the key market players operating in the coronary stents market include Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, TERUMO CORPORATION, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.
Coronary Stents Market Recent Developmental Activities:
In August 2020, Boston Scientific Corporation received FDA approval for its SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail and Over-The-Wire).
In October 2020, Biosensors received the CE Mark for BioFreedomUltra, a new drug-coated coronary stent system with a thin strut (84µm) CoCr polymer and Biosensors' Biolimus A9 drug.
Key Takes Away from the Coronary Stents Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the global coronary stents market.
Various opportunities available for the other competitor in the coronary stents market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for coronary stents market growth in the coming future?
Target Audience who can be benefited from Coronary Stents Market Report Study
Coronary Stents providers
Research organizations and consulting companies
Coronary Stents-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Coronary Stents
Various End-Users who want to know more about the coronary stents market and the latest technological developments in the coronary stents market.
Frequently Asked Questions for Coronary Stents Market:
1. What are Coronary Stents?
Coronary stents are small, expandable, wired mesh tubes that help in the widening of a clogged artery and restore adequate blood flow to the heart. These stents are predominantly of two categories bare metal and drug-eluting.
2. What is the market for global coronary stents?
The global coronary stents market was valued at USD 9.27 billion in 2023, growing at a CAGR of 7.51% during the forecast period from 2024 to 2030, to reach USD 14.28 billion by 2030.
3. What are the drivers for global coronary stents?
The major drivers driving the demand for coronary stents are the growing burden of the old age population susceptible to various cardiovascular disorders, shifting preferences towards minimally invasive surgeries, and technological advancement in the product line, among others.
4. Who are the key players operating in global coronary stents?
Some of the key market players operating in the coronary stents market include Medtronic, Abbott, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, TERUMO CORPORATION, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., and others.
5. Which region has the highest share in the coronary stents market?
North America is anticipated to dominate the overall coronary stents market during the forecast period, 2024-2030 due to the improved healthcare infrastructure, and favorable reimbursement scenario in the region. Moreover, recent product approvals and the presence of key manufacturers are also factors contributing to the highest market share.
Table of Contents
1. Coronary Stents Market Report Introduction
2. Coronary Stents Market Executive Summary
- 2.1. Scope of the Study
- 2.2. Market at Glance
- 2.3. Competitive Assessment
3. Regulatory Analysis
- 3.1. The United States
- 3.2. Europe
- 3.3. Japan
- 3.4. China
4. Coronary Stents Market Key Factors Analysis
- 4.1. Coronary Stents Market Drivers
- 4.1.1. Rising prevalence of cardiovascular disorders (CVDs)
- 4.1.2. Growing number of PCI (Percutaneous Coronary Intervention) procedures
- 4.1.3. Increasing demand for minimally invasive surgeries
- 4.1.4. Technological advancements
- 4.2. Coronary Stents Market Restraints and Challenges
- 4.2.1. Product recalls
- 4.2.2. Stringent regulatory approvals
- 4.3. Coronary Stents Market Opportunities
- 4.3.1. Shift toward bioresorbable vascular scaffolds
- 4.3.2. Growth opportunities in emerging countries
5. Coronary Stents Porter's Five Forces Analysis
- 5.1. Bargaining Power of Suppliers
- 5.2. Bargaining Power of Consumers
- 5.3. Threat of New Entrants
- 5.4. Threat of Substitutes
- 5.5. Competitive Rivalry
6. Coronary Stents Market layout
- 6.1. By Product Type
- 6.1.1. Bare Metal Stents
- 6.1.2. Drug Eluting Stents
- 6.1.3. Drug-Coated Stents
- 6.2. By Material
- 6.2.1. Metals
- 6.2.1.1. Stainless Steel
- 6.2.1.2. Cobalt-Chromium (CoCr)
- 6.2.1.3. Platinum-Chromium (PtCr)
- 6.2.1.4. Nitinol
- 6.2.2. Polymers
- 6.2.1. Metals
- 6.3. By End-User
- 6.3.1. Hospitals
- 6.3.2. Ambulatory Surgical Centers
- 6.3.3. Others
- 6.4. By Geography
- 6.4.1. North America Coronary Stents Market Size in USD million (2021-2030)
- 6.4.1.1. United States Coronary Stents Market Size in USD million (2021-2030)
- 6.4.1.2. Canada Coronary Stents Market Size in USD million (2021-2030)
- 6.4.1.3. Mexico Coronary Stents Market Size in USD million (2021-2030)
- 6.4.2. Europe Coronary Stents Market Size in USD million (2021-2030)
- 6.4.2.1. France Coronary Stents Market Size in USD million (2021-2030)
- 6.4.2.2. Germany Coronary Stents Market Size in USD million (2021-2030)
- 6.4.2.3. United Kingdom Coronary Stents Market Size in USD million (2021-2030)
- 6.4.2.4. Italy Coronary Stents Market Size in USD million (2021-2030)
- 6.4.2.5. Spain Coronary Stents Market Size in USD million (2021-2030)
- 6.4.2.6. Rest of Europe Coronary Stents Market Size in USD million (2021-2030)
- 6.4.3. Asia-Pacific Coronary Stents Market Size in USD million (2021-2030)
- 6.4.3.1. China Coronary Stents Market Size in USD million (2021-2030)
- 6.4.3.2. Japan Coronary Stents Market Size in USD million (2021-2030)
- 6.4.3.3. India Coronary Stents Market Size in USD million (2021-2030)
- 6.4.3.4. Australia Coronary Stents Market Size in USD million (2021-2030)
- 6.4.3.5. South Korea Coronary Stents Market Size in USD million (2021-2030)
- 6.4.3.6. Rest of Asia Pacific Coronary Stents Market Size in USD million (2021-2030)
- 6.4.4. Rest of the World (RoW) Coronary Stents Market Size in USD million (2021-2030)
- 6.4.4.1. Middle East Coronary Stents Market Size in USD million (2021-2030)
- 6.4.4.2. Africa Coronary Stents Market Size in USD million (2021-2030)
- 6.4.4.3. South America Coronary Stents Market Size in USD million (2021-2030)
- 6.4.1. North America Coronary Stents Market Size in USD million (2021-2030)
7. Coronary Stents Company and Product Profiles
- 7.1. Medtronic
- 7.1.1. Company Overview
- 7.1.2. Company Snapshot
- 7.1.3. Financial Overview
- 7.1.4. Product Listing
- 7.1.5. Entropy
- 7.2. Abbott
- 7.2.1. Company Overview
- 7.2.2. Company Snapshot
- 7.2.3. Financial Overview
- 7.2.4. Product Listing
- 7.2.5. Entropy
- 7.3. Boston Scientific Corporation
- 7.3.1. Company Overview
- 7.3.2. Company Snapshot
- 7.3.3. Financial Overview
- 7.3.4. Product Listing
- 7.3.5. Entropy
- 7.4. Biosensors International Group, Ltd.
- 7.4.1. Company Overview
- 7.4.2. Company Snapshot
- 7.4.3. Financial Overview
- 7.4.4. Product Listing
- 7.4.5. Entropy
- 7.5. BIOTRONIK
- 7.5.1. Company Overview
- 7.5.2. Company Snapshot
- 7.5.3. Financial Overview
- 7.5.4. Product Listing
- 7.5.5. Entropy
- 7.6. B. Braun Melsungen AG
- 7.6.1. Company Overview
- 7.6.2. Company Snapshot
- 7.6.3. Financial Overview
- 7.6.4. Product Listing
- 7.6.5. Entropy
- 7.7. Terumo Corporation
- 7.7.1. Company Overview
- 7.7.2. Company Snapshot
- 7.7.3. Financial Overview
- 7.7.4. Product Listing
- 7.7.5. Entropy
- 7.8. STENTYS SA
- 7.8.1. Company Overview
- 7.8.2. Company Snapshot
- 7.8.3. Financial Overview
- 7.8.4. Product Listing
- 7.8.5. Entropy
- 7.9. MicroPort Scientific Corporation
- 7.9.1. Company Overview
- 7.9.2. Company Snapshot
- 7.9.3. Financial Overview
- 7.9.4. Product Listing
- 7.9.5. Entropy
- 7.10. Meril Life Sciences Pvt. Ltd.
- 7.10.1. Company Overview
- 7.10.2. Company Snapshot
- 7.10.3. Financial Overview
- 7.10.4. Product Listing
- 7.10.5. Entropy
- 7.11. Vascular Concepts
- 7.11.1. Company Overview
- 7.11.2. Company Snapshot
- 7.11.3. Financial Overview
- 7.11.4. Product Listing
- 7.11.5. Entropy
- 7.12. COOK
- 7.12.1. Company Overview
- 7.12.2. Company Snapshot
- 7.12.3. Financial Overview
- 7.12.4. Product Listing
- 7.12.5. Entropy
- 7.13. SCITECH Medical
- 7.13.1. Company Overview
- 7.13.2. Company Snapshot
- 7.13.3. Financial Overview
- 7.13.4. Product Listing
- 7.13.5. Entropy
- 7.14. Lepu Medical Technology Co., Ltd.
- 7.14.1. Company Overview
- 7.14.2. Company Snapshot
- 7.14.3. Financial Overview
- 7.14.4. Product Listing
- 7.14.5. Entropy
- 7.15. OrbusNeich Medical Company Limited
- 7.15.1. Company Overview
- 7.15.2. Company Snapshot
- 7.15.3. Financial Overview
- 7.15.4. Product Listing
- 7.15.5. Entropy
8. KOL Views
9. Project Approach
10. DelveInsight Capabilities
11. About DelveInsight
12. Disclaimer & Contact Us
List of Tables
- Table 1: Competitive Analysis
- Table 2: Coronary Stents Market in Global (2021-2030)
- Table 3: Coronary Stents Market in Global by Product Type (2021-2030)
- Table 4: Coronary Stents Market in Global by Material (2021-2030)
- Table 5: Coronary Stents Market in Global by End-User (2021-2030)
- Table 6: Coronary Stents Market in Global by Geography (2021-2030)
- Table 7: Coronary Stents Market in North America (2021-2030)
- Table 8: Coronary Stents Market in the US (2021-2030)
- Table 9: Coronary Stents Market in Canada (2021-2030)
- Table 10: Coronary Stents Market in Mexico (2021-2030)
- Table 11: Coronary Stents Market in Europe (2021-2030)
- Table 12: Coronary Stents Market in France (2021-2030)
- Table 13: Coronary Stents Market in Germany (2021-2030)
- Table 14: Coronary Stents Market in the United Kingdom (2021-2030)
- Table 15: Coronary Stents Market in Italy (2021-2030)
- Table 16: Coronary Stents Market in Spain (2021-2030)
- Table 17: Coronary Stents Market in Rest of Europe (2021-2030)
- Table 18: Coronary Stents Market in Asia-Pacific (2021-2030)
- Table 19: Coronary Stents Market in China (2021-2030)
- Table 20: Coronary Stents Market in Japan (2021-2030)
- Table 21: Coronary Stents Market in India (2021-2030)
- Table 22: Coronary Stents Market in Australia (2021-2030)
- Table 23: Coronary Stents Market in South Korea (2021-2030)
- Table 24: Coronary Stents Market in Rest of Asia-Pacific (2021-2030)
- Table 25: Coronary Stents Market in the Rest of the World (2021-2030)
- Table 26: Coronary Stents Market in the Middle East (2021-2030)
- Table 27: Coronary Stents Market in Africa (2021-2030)
- Table 28: Coronary Stents Market in South America (2021-2030)
List of Figures
- Figure 1: Competitive Analysis
- Figure 2: Coronary Stents Market in Global (2021-2030)
- Figure 3: Coronary Stents Market in Global by Product Type (2021-2030)
- Figure 4: Coronary Stents Market in Global by Material (2021-2030)
- Figure 5: Coronary Stents Market in Global by End-User (2021-2030)
- Figure 6: Coronary Stents Market in Global by Geography (2021-2030)
- Figure 7: Coronary Stents Market in North America (2021-2030)
- Figure 8: Coronary Stents Market in the US (2021-2030)
- Figure 9: Coronary Stents Market in Canada (2021-2030)
- Figure 10: Coronary Stents Market in Mexico (2021-2030)
- Figure 11: Coronary Stents Market in Europe (2021-2030)
- Figure 12: Coronary Stents Market in France (2021-2030)
- Figure 13: Coronary Stents Market in Germany (2021-2030)
- Figure 14: Coronary Stents Market in the United Kingdom (2021-2030)
- Figure 15: Coronary Stents Market in Italy (2021-2030)
- Figure 16: Coronary Stents Market in Spain (2021-2030)
- Figure 17: Coronary Stents Market in Rest of Europe (2021-2030)
- Figure 18: Coronary Stents Market in Asia-Pacific (2021-2030)
- Figure 19: Coronary Stents Market in China (2021-2030)
- Figure 20: Coronary Stents Market in Japan (2021-2030)
- Figure 11: Coronary Stents Market in India (2021-2030)
- Figure 22: Coronary Stents Market in Australia (2021-2030)
- Figure 23: Coronary Stents Market in South Korea (2021-2030)
- Figure 24: Coronary Stents Market in the Rest of Asia-Pacific (2021-2030)
- Figure 25: Coronary Stents Market in the Rest of the World (2021-2030)
- Figure 26: Coronary Stents Market in the Middle East (2021-2030)
- Figure 27: Coronary Stents Market in Africa (2021-2030)
- Figure 28: Coronary Stents Market in South America (2021-2030)
- Figure 29: Market Drivers
- Figure 30: Market Barriers
- Figure 31: Market Opportunities
- Figure 32: PORTER's Five Force Analysis
